Medical histories of patients treated with budesonide Case report
Article Sidebar
Main Article Content
Abstract
Respiratory tract diseases are the most common chronic diseases in both children and adults. This results in the need for effective drugs to control chronic diseases and to work quickly and well in acute conditions. Such drugs are glucocorticosteroids administered by inhalation. All recommendations place inhaled glucocorticosteroids as one of the basic drugs in the treatment of respiratory diseases in children and adults. One of the best-known and studied GCs is budesonide. Budesonide is a synthetic, non-halogenated glucocorticosteroid with a very strong antiallergic and anti-inflammatory effect. It is effective both in chronic diseases (e.g., asthma and COPD) and in emergencies (e.g., exacerbation of chronic diseases, acute laryngitis). This article presents typical examples of clinical use of inhaled budesonide in acute subglottic laryngitis (croup), chronic obstructive pulmonary disease (COPD) and bronchial asthma. In all of these cases, budesonide has proven to be an effective and safe drug.
Article Details
Copyright © by Medical Education. All rights reserved.
References
2. Emeryk A, Pirożyński M, Mazurek H et al. Polski przewodnik inhalacyjny. Via Medica, Gdańsk 2015: 1-22.
3. Murphy RK, Hong JG, Wandalsen G et al. Nebulized Inhaled Corticosteroids in Asthma Treatment in Children 5 Years or Younger: A Systematic Review and Global Expert Analysis. Allergy Clin Immunol Pract. 2020; 8(6): 1815-27.
4. Sybilski AJ. Pseudokrup – ostre zapalenie krtani. Alergoprofil. 2022; 18(1): 1-6.
5. Mazurek H, Bręborowicz A, Doniec Z et al. Acute subglottic laryngitis. Etiology, epidemiology, pathogenesis and clinical picture. Adv Respir Med. 2019; 87: 308-16.
6. Gates A, Johnson DW, Klassen TP. Glucocorticoids for Croup in Children. JAMA Pediatr. 2019; 173(6): 595-6.
7. Hryniewicz W, Albrecht P, Radzikowski A (ed). Rekomendacje postępowania w pozaszpitalnych zakażeniach układu oddechowego. Narodowy Program Ochrony Antybiotyków 2016.
8. Bjornson C, Russell KF, Vandermeer B et al. Nebulized epinephrine for croup in children. Cochrane Database Syst Rev. 2011; (2): CD006619.
9. Cetinkaya F, Tüfekçi BS, Kutluk G. A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. Int J Pediatr Otorhinolaryngol. 2004; 68(4): 453-6.
10. Petrocheilou A, Tanou K, Kalampouka E et al. Viral croup: diagnosis and a treatment algorithm. Pediatr Pulmonol. 2014; 49(5): 421-9.
11. Doniec Z, Mastalerz-Migas A, Bręborowicz A et al. ReKOMendacje Postępowania w AStmie wczesnodziecięcej dla lekarzy Podstawowej Opieki Zdrowotnej – KOMPAS POZ. Fam Med Prim Care Rev. 2016; 18(2): 181-19.
12. Bartholow AK, Deshaies DM, Skoner JM et al. A critical review of the effects of inhaled corticosteroids on growth. Allergy Asthma Proc. 2013; 34(5): 391-407.
13. Ducharme FM, Sharon DD, Radhakrishnan D et al. Diagnosis and management of asthma in preschoolers: a Canadian Thoracic Society and Canadian Paediatric Society position paper. Can Respir J. 2015; 22(3): 135-43.
14. Herzog R, Cunningham-Rundles S. Pediatric asthma: natural history, assessment and treatment. Mt Sinai J Med. 2011; 78(5): 645-60.
15. Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2022 Report (access: 24.08.2022).
16. Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest. 2009; 135: 786-93.